Vancouver’s latest tourist attraction

Magic Mushroom Stores Are Open in Canada — But They’re Still Illegal

Mushroom dispensaries are rapidly popping up across Vancouver…even though they’re still illegal.

The Coca Leaf Cafe & Mushroom Dispensary is one of a handful of dispensaries that opened in the city this year. Customers can purchase high and low doses of psilocybin mushrooms, growing kits, peyote (a psychedelic cactus), kratom (a tropical tree with an opioid-like effect), and coca leaf products (the plant used to make cocaine).

Earlier this year, Vancouver applied to decriminalize the possession of 15 different drugs including psilocybin. Even though the legislation has yet to be passed, the dispensary owner says he’s not overly worried about law enforcement.

Even Paul Lewin, a Toronto lawyer who’s working with TheraPsil to improve Health Canada’s exemption process, thinks the dispensary owner would have a strong case if he did get busted.

“We have enough research. If we fought this in court, we would win,” Lewin said. “We could clearly establish that it’s safe and that it is effective.”

PDF of article

Psychedelic “smart shops” to open in Jamaica

Psychedelic Mushroom Shops Reach The Americas

Many psychedelic companies are being drawn to Jamaica, one of the only countries where it’s legal to cultivate, extract, and sell psilocybin mushrooms. Silo Wellness is partnering with Mushe Inc. to open the first “smart shop” in the Western hemisphere, a psychedelic mushroom retail outlet that will sell functional and psychedelic mushrooms in various forms to locals and tourists.

Psyence Group formally began operations in Jamaica under its wholly owned subsidiary, Psyence Jamaica Ltd., which will focus on psilocybin treatment for patients in palliative care. To take on the new market, Psyence Jamaica is in collaboration with LONACAS Inc., a Jamaican clinical research company, and MycoMeditations, a “psilocybin wellness destination experience” in Treasure Beach, Jamaica.

Wake Network Inc. received clearance to conduct a “first-of-its-kind” clinical trial at a Jamaican university, which will study the effect of microdosing on depression and anxiety.

PDF of article

PDF of article 2

PDF of article 3